REPH Stock Price, News & Analysis
Company Description
REPH (NASDAQ: REPH) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $123.2M.
REPH stock has declined 43.4% over the past year.
This page provides a comprehensive overview of REPH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
REPH (REPH) stock. Over the past 12 months, the stock has lost 43.4%. At a market capitalization of $123.2M, REPH is classified as a micro-cap stock with approximately 56.4M shares outstanding.
Latest News
REPH has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, clinical trial, management. View all REPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
REPH Company Profile & Sector Positioning
REPH (REPH) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing REPH often look at related companies in the same sector, including (GNTW), (HBORF), Gage Growth (GAEGF), (MNKPF), and (LNDC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate REPH's relative position within its industry.